Overview
Ben Gerber is a primary care provider, practicing in Internal Medicine in Worcester, Massachusetts. Dr. Gerber is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Adie Syndrome, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Obesity.
His clinical research consists of co-authoring 101 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
55 Lake Ave N, Worcester, MA 01655
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Beth Israel Deaconess Medical Center - Hematology/Oncology
David Mcdermott is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Mcdermott is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Melanoma, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Nephrectomy.
Beth Israel Deaconess Medical Center - Hematology/Oncology
David Einstein is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Einstein is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Prostatectomy.
Kenneth Thomas is a primary care provider, practicing in Internal Medicine in Manchester, New Hampshire. Dr. Thomas is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, and Glucocorticoid-Remediable Aldosteronism.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Adie SyndromeDr. Gerber isAdvanced. Learn about Adie Syndrome.
- Type 2 Diabetes (T2D)Dr. Gerber isAdvanced. Learn about Type 2 Diabetes (T2D).
- Experienced
- Chromophobe Renal Cell CarcinomaDr. Gerber isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Chronic Kidney DiseaseDr. Gerber isExperienced. Learn about Chronic Kidney Disease.
- Clear Cell SarcomaDr. Gerber isExperienced. Learn about Clear Cell Sarcoma.
- COVID-19Dr. Gerber isExperienced. Learn about COVID-19.
- Diabetic RetinopathyDr. Gerber isExperienced. Learn about Diabetic Retinopathy.
- Familial Wilms Tumor 2Dr. Gerber isExperienced. Learn about Familial Wilms Tumor 2.